Unlock the future of disease research with our revolutionary Paired-Tag technologyDesigned to decipher the complexity of human diseases, our technology delves into the heart of epigenetic dysfunction, a key player in phenomena like cancer therapeutic resistance. Our innovation illuminates the intricate regulatory programs underlying diseases, offering a gateway to more effective treatments. As a trusted partner to dozens of researchers worldwide, we're shaping the next generation of clinical assays. Explore the untapped potential of the epigenome with us, your guide in the frontier of single-cell multi-omics technologies. Together, we can revolutionize our understanding and treatment of disease.

EpiGenie is a team of folks who scour through PubMed, watch out for interesting epigenetics press releases, conduct interviews with epigenetics researchers, and work closely with the technology providers to stay on top of the most applicable work driving epigenetics-related research. Current contributions include 3 to 5 blog posts a month on related topics.

Aid in the upkeep of the Stem Cell and Stem Cells Translational Medicine journals online Portal website, by writing reviews, short news articles and covering Conferences.Also run the Facebook/Twitter website for Stem Cell and Stem Cells Translational Medicine journals, by posting up to date stem cell news and updates from the Stem Cell and Stem Cells Translational Medicine journals.

In my role as technical advisor, I aid in the writing, and expansion of grant proposals, including NIH, to aid groups to add impact to their proposals and heighten their chance of a successful application. I also aid groups in manuscript writing and other aspects of scientific writing in english.http://generabiotech.com/Under the philosophy of translational research and the need for an open innovation, this company was born to generate knowledge as well as to pinpointing scientific findings with strong commercial potential for catalyzing their transformation into value in the market through partnerships with the academia and the business, improving the ability to turn ideas into realities that provide solutions to biotechnology and medical needs not yet covered. Thus, Genera Biotech has a role as facilitator, support and sharing, to effectively promote research and innovation in any field of the biotechnology focused mainly on human health.Our activity results in future benefits for all stakeholders: economic returns to the originators of technology and for businesses and investors who have been involved in its development, and a benefit to the society which will see how their public investment in research is converted in tangible products which also improve their quality of life.

Research into human embryonic stem cells, induced pluripotent stem cells and primordial germ cells.Involves analysis at the transcript, protein and epigenetic levels in hESC and hIPSC.Currently studying the role of proteasome subunits in pluripotency, DNA damage pathways, epigenetic differences between hESC and iPSC, the role of epigenetic modifiers in hESC pluripotency and the role of mitochondria and stress response in hESC and iPSC.This work involves multidisciplinary research within a large group of researchers.

Research into human embryonic stem cell research, induced pluripotent stem cells and primordial germ cells.Involves analysis at the transcript, protein and epigenetic levels. Currently studying the role of proteasome subunits in pluripotency, DNA damage pathways in hESC and iPSC, epigenetic differences between hESC and iPSC and the role of epigenetic modifiers in hESC pluripotency.Involves multidisciplinary research within a large group of researchers.

PhD Student studying the role of epigenetic modifications in the control of the telomerase gene promoters (hTR and hTERT) and the potential significance in senescence, telomerase activity and the ALT method of telomere maintenance, and also in haematopoetic progenitors in CML samples This was undertaken with Professor Nicol Keith at the Centre for Oncology & Applied Pharmacology (Cancer Research UK) at the Beatson Laboratories in Glasgow.This involved various techniques, including tissue culture, chromatin immunoprecipitation and quantitative PCR analysis amongst others.